发明名称 FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ss, DOLLAR G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
摘要 A novel crystalline form of [R-(R*,R*)]-2-(4-fluorophenyl)-ss, delta -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid hemi calcium salt designated as Form V is characterized by its X-ray powder diffraction and/or solid state NMR is described, as well as methods for the preparation which is useful as an agent for treating hyperlipidemia and hypercholesterolemia.
申请公布号 WO02057229(A1) 申请公布日期 2002.07.25
申请号 WO2001IN00006 申请日期 2001.01.19
申请人 BIOCON INDIA LIMITED;MATHEW, JOY;GANESH, SAMBASIVAM 发明人 MATHEW, JOY;GANESH, SAMBASIVAM
分类号 A61K31/40;A61P3/06;C07B61/00;C07D207/34;C07F5/02;(IPC1-7):C07D207/34 主分类号 A61K31/40
代理机构 代理人
主权项
地址